Aktienanalyse zu Globe Life Inc (GL)GLGlobe Life Inc

Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company's segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It operates in the Financials sector (LIFE INSURANCE industry).

Globe Life Inc is currently priced at $168.77, which is below several analyst price targets, including $197 from Morgan Stanley and $225 from TD Cowen. However, the stock has an RSI of 68.107, indicating it is nearing overbought territory, suggesting caution. Additionally, insider selling has increased by 1066.49% over the last month, which raises concerns about insider confidence. Given these factors, it may be prudent to hold rather than buy at this time.